Literature DB >> 2712571

Mouse liver P450Coh: genetic regulation of the pyrazole-inducible enzyme and comparison with other P450 isoenzymes.

M A Lang1, R Juvonen, P Järvinen, P Honkakoski, H Raunio.   

Abstract

Genetic experiments with two inbred strains of mice, AKR/J and DBA/2N, show a single major gene inheritance of additive mode for pyrazole-inducible coumarin 7-hydroxylase. Intragroup variation in the enzyme activity further suggests the contribution of minor modifying genes to the final enzyme activity. Western blot analysis with a polyclonal antibody raised against the purified isozyme P450Coh (highly active in the 7-hydroxylation of coumarin) showed that a difference in the amounts of P450Coh protein between the D2 and AKR mice is the reason for the differences in the enzyme activity between the two mouse strains. Accordingly, changes at the regulatory level rather than at the structural gene would explain the genetic difference in the activity of coumarin 7-hydroxylase. This hypothesis is further supported by the identical Km values of the basal and induced enzyme. The inducibility of coumarin 7-hydroxylase by phenobarbital (PB) and its genetic regulation have been previously studied by A. W. Wood and colleagues ((1974) Science 185, 612-614; (1979); J. Biol. Chem. 254, 5641-5646 and 5647-5651). Our present experiments show that the regulation is the same for the pyrazole-inducible enzyme. Furthermore the experiments with anti-P450Coh antibody show that the PB- and pyrazole-inducible proteins have the same molecular weight and are immunologically indistinguishable. This suggests that PB and pyrazole may induce the same enzyme. Immunoinhibition of microsomal coumarin 7-hydroxylase is practically 100% for control animals and after pretreatment with pyrazole or PB. This suggests that in each case the same or immunologically closely related proteins are metabolizing coumarin and that the P450Coh may be the only P450 isoenzyme in mouse liver microsomes catalyzing the 7-hydroxylation of coumarin. The N-terminal amino acid sequence of P450Coh was found to be identical with those from Type I and Type II genes of the mouse P45015 alpha family for the first 21 amino acids. With rat PB-inducible P450b the homology is only 33%. Also the immunological properties of P450Coh are different from those of P450b. This may suggest that P450Coh has a closer association to the steroid 15 alpha-hydroxylase gene family than to the P450IIB subfamily of phenobarbital-inducible isoenzymes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2712571     DOI: 10.1016/0003-9861(89)90264-6

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

1.  Increased oxidative DNA damage and hepatocyte overexpression of specific cytochrome P450 isoforms in hepatitis of mice infected with Helicobacter hepaticus.

Authors:  M A Sipowicz; P Chomarat; B A Diwan; M A Anver; Y C Awasthi; J M Ward; J M Rice; K S Kasprzak; C P Wild; L M Anderson
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.

Authors:  L M Forrester; C J Henderson; M J Glancey; D J Back; B K Park; S E Ball; N R Kitteringham; A W McLaren; J S Miles; P Skett
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

3.  Human and mouse liver coumarin 7-hydroxylases do not metabolize warfarin in vitro.

Authors:  P Honkakoski; P Arvela; R Juvonen; M A Lang; M Kairaluoma; O Pelkonen
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

4.  Interindividual variability of coumarin 7-hydroxylation in a Turkish population.

Authors:  M Iscan; H Rostami; M Iscan; T Güray; O Pelkonen; A Rautio
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

5.  Effect of pyrazole, cobalt and phenobarbital on mouse liver cytochrome P-450 2a-4/5 (Cyp2a-4/5) expression.

Authors:  B Hahnemann; P Salonpää; M Pasanen; J Mäenpää; P Honkakoski; R Juvonen; M A Lang; O Pelkonen; H Raunio
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

6.  Regulation of Cyp2a5 transcription in mouse primary hepatocytes: roles of hepatocyte nuclear factor 4 and nuclear factor I.

Authors:  Johanna Ulvila; Satu Arpiainen; Olavi Pelkonen; Kaoru Aida; Tatsuya Sueyoshi; Masahiko Negishi; Jukka Hakkola
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

7.  Response of mouse liver coumarin 7-hydroxylase activity to hepatotoxins: dependence on strain and agent and comparison to other monooxygenases.

Authors:  P Pellinen; F Stenbäck; A Rautio; O Pelkonen; M Lang; M Pasanen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

8.  Cell-specific expression of CYP2A5 in the mouse respiratory tract: effects of olfactory toxicants.

Authors:  Elena Piras; Anna Franzén; Estíbaliz L Fernández; Ulrika Bergström; Françoise Raffalli-Mathieu; Matti Lang; Eva B Brittebo
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

9.  Tissue and sex-dependent differences in CYP2A activities in hamsters.

Authors:  P Pelkonen; M Lang; M Pasanen
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

10.  Pyrazole induced oxidative liver injury independent of CYP2E1/2A5 induction due to Nrf2 deficiency.

Authors:  Yongke Lu; Pengfei Gong; Arthur I Cederbaum
Journal:  Toxicology       Date:  2008-08-03       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.